Skip to main
SRRA
SRRA logo

Sierra Oncology (SRRA)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Sierra Oncology (SRRA) Stock

About Sierra Oncology (SRRA)

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer tre...read more
Market cap$1.34B
Today's volume
Revenue (TTM)
Avg. daily volume628.35K
EBITDA (TTM)
Open
Price / earnings ratio-8.13x
Today's range
Debt / equity
52 week range$14.91 - $55.19
5 year debt / equity1.26x
Beta (LTM)0.52x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 6, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 22, 2025, the market cap for SRRA stock is $1.35B

The current P/E ratio for SRRA stock is -8.13

The 52-week high for SRRA stock is $55.19. The current SRRA stock price $undefined is 100.00% below its 52-week high

The 52-week low for SRRA stock is $14.91. The current SRRA stock price $undefined has increased 100.00% from its 52-week low

No, the SRRA stock does not pay dividends to its shareholders

How to buy SRRA stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in SRRA stock

    Navigate to the Explore page. Then, type SRRA into the search bar. When you see SRRA stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased SRRA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Sierra Oncology Stock Earnings

The value each SRRA share was expected to gain vs. the value that each SRRA share actually gained.

Sierra Oncology (SRRA) reported Q1 2022 earnings per share (EPS) of -$1.33, missing estimates of -$1.03 by 29.13%. In the same quarter last year, Sierra Oncology's earnings per share (EPS) was -$1.46. Sierra Oncology is expected to release next earnings on 05/06/2022, with an earnings per share (EPS) estimate of $0.

Buy Sierra Oncology (SRRA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.